Phase II Study of... www.astctjournal.org

Immunological and Clinical... www.mdpi.com

Prophylactic modified donor... www.nature.com

Reduced-intensity... www.astctjournal.org

How I treat high-risk acute... www.sciencedirect.com

Feasibility, safety, and... link.springer.com

How I treat high-risk acute... www.sciencedirect.com

Long-term results and GvHD... www.nature.com

Frontiers | The graft... www.frontiersin.org

Donor lymphocyte infusion... www.thelancet.com

Feasibility, safety, and... link.springer.com

Navigating Treatment... ascopubs.org

How I treat high-risk acute... www.sciencedirect.com

The graft-versus-leukemia... link.springer.com

How I treat high-risk acute... www.sciencedirect.com

Comparison of single-dose... www.sciencedirect.com

Risk-adapted donor... www.nature.com

Frontiers | Dendritic... www.frontiersin.org

Donor Lymphocyte Infusion... ascopubs.org

Dose escalation... www.nature.com